Have a feature idea you'd love to see implemented?
Let us know!
OPTN OptiNose Inc
Price (delayed)
$0.7761
Market cap
$117.02M
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$0.34
Enterprise value
$150.95M
Optinose is a specialty pharmaceutical company focused on serving the needs of patients cared for by ear, nose and throat (ENT) and allergy specialists. Optinose has offices in the U.S.
Highlights
The quick ratio has surged by 71% since the previous quarter
The equity has surged by 57% since the previous quarter and by 38% year-on-year
OptiNose's net income has decreased by 33% from the previous quarter but it has increased by 12% YoY
OPTN's EPS is up by 29% YoY but it is down by 26% from the previous quarter
Key stats
What are the main financial stats of OPTN
Market
Valuations
Earnings
Shares outstanding
150.78M
Market cap
$117.02M
Enterprise value
$150.95M
Price to earnings (P/E)
N/A
Price to book (P/B)
N/A
Price to sales (P/S)
1.52
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
2.01
Revenue
$75.06M
EBIT
-$20.96M
EBITDA
-$20.58M
Free cash flow
-$35.54M
Per share
Balance sheet
Liquidity
EPS
-$0.34
Free cash flow per share
-$0.24
Book value per share
-$0.38
Revenue per share
$0.51
TBVPS
$0.89
Total assets
$131.87M
Total liabilities
$174.73M
Debt
$125.29M
Equity
-$42.85M
Working capital
$96.23M
Debt to equity
-2.92
Current ratio
3.94
Quick ratio
3.43
Net debt/EBITDA
-1.65
Margins
Efficiency
Dividend
EBITDA margin
-27.4%
Gross margin
89.9%
Net margin
-54.5%
Operating margin
-25.1%
Return on assets
-38.5%
Return on equity
N/A
Return on invested capital
-33.4%
Return on capital employed
-21.1%
Return on sales
-27.9%
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
OPTN stock price
How has the OptiNose stock price performed over time
Intraday
-1.81%
1 week
2.74%
1 month
7.79%
1 year
-26.78%
YTD
-39.84%
QTD
15.84%
Financial performance
How have OptiNose's revenue and profit performed over time
Revenue
$75.06M
Gross profit
$67.49M
Operating income
-$18.83M
Net income
-$40.91M
Gross margin
89.9%
Net margin
-54.5%
The operating margin has surged by 52% year-on-year but it has declined by 13% since the previous quarter
The operating income has surged by 50% year-on-year but it has declined by 14% since the previous quarter
OptiNose's net income has decreased by 33% from the previous quarter but it has increased by 12% YoY
OPTN's net margin is down by 31% QoQ but it is up by 15% YoY
Growth
What is OptiNose's growth rate over time
Valuation
What is OptiNose stock price valuation
P/E
N/A
P/B
N/A
P/S
1.52
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
2.01
OPTN's EPS is up by 29% YoY but it is down by 26% from the previous quarter
The equity has surged by 57% since the previous quarter and by 38% year-on-year
OPTN's price to sales (P/S) is 57% less than its 5-year quarterly average of 3.6 and 26% less than its last 4 quarters average of 2.1
OptiNose's revenue has increased by 3.9% YoY
Efficiency
How efficient is OptiNose business performance
OPTN's ROS has plunged by 89% from the previous quarter but it is up by 28% YoY
The ROA has contracted by 25% from the previous quarter but it has grown by 2.3% YoY
The company's return on invested capital rose by 10% QoQ
Dividends
What is OPTN's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for OPTN.
Financial health
How did OptiNose financials performed over time
OptiNose's total assets is 25% less than its total liabilities
The quick ratio has surged by 71% since the previous quarter
OPTN's current ratio has soared by 59% since the previous quarter
OptiNose's debt to equity has shrunk by 121% QoQ and by 57% YoY
The equity has surged by 57% since the previous quarter and by 38% year-on-year
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise
specified. Data from 
and Sharadar.